| Literature DB >> 25815098 |
Ahmed Hasanin1, Akram Eladawy1, Hossam Mohamed1, Yasmin Salah1, Ahmed Lotfy1, Hanan Mostafa1, Doaa Ghaith2, Ahmed Mukhtar1.
Abstract
INTRODUCTION: The prevalence of extensively drug resistant gram negative bacilli (XDR-GNB) is rapidly progressing; however in Egypt data are sparse. We conducted the present study to quantify the incidence, risk factors and outcome of patients harboring XDR-GNB.Entities:
Keywords: Extensive drug resistance; critically ill patients; gram negative bacilli
Mesh:
Substances:
Year: 2014 PMID: 25815098 PMCID: PMC4366122 DOI: 10.11604/pamj.2014.19.177.4307
Source DB: PubMed Journal: Pan Afr Med J
Prevalence of XDR isolates among different organisms
| Isolate | Number of cultures (%) | XDR strains (%) |
|---|---|---|
| P. aeruginosa | 60 | 63% |
| K. pneumonia | 62 | 52% |
| A. baumannii | 54 | 86% |
| E. coli | 34 | 47% |
| P. mirabilis | 13 | 61% |
Figure 1Prevalence of XDR strains among different sites of isolates. P value = 0.003
Antibiotic susceptibility pattern of the most five abundant gram negative isolates
| C3 | C4 | Quinolones | Amikacin | Tazocin | Carbapinems | Colistin | |
|---|---|---|---|---|---|---|---|
| P. aeruginosa | 13% | 16% | 33.9% | 38.3% | 68.8% | 39% | 87.5% |
| A. baumannii | 3.7% | 2% | 18.5% | 17% | 20% | 24.5% | 100% |
| K. pneumonia | 11.3% | 10.5% | 45.9% | 45.8% | 35.7% | 88.7% | 100% |
| E. coli | 11.8% | 9.7% | 39.4% | 69.7% | 66.7% | 97.1% | 100% |
| P. mirabilis | 27.3% | 30% | 41.7% | 36.4% | 0% | 83.3% | 100% |
C3: 3rd generation cephalosporines, C4: 4th generation caphalosporines
Demographic data, risk factors, and outcome of MDR and Non MDR groups of patients (Univariate analysis). Data are represented as mean (SD) and frequency
| XDR group (n = 152) | Non XDR group (n = 82) | P value | |
|---|---|---|---|
| Prevalence | 65% | 35% | |
| Age | 36(±31) | 30(±19) | |
| APACHE II | 19(±9) | 23(±10) | |
| Gender | 0.4 | ||
| Male | 62.9% | 67.9% | |
| Female | 37.1% | 32.1% | |
| Ventilation | 84.7% | 79% | 0.3 |
| Relaparotomy | 55% | 25% | 0.04 |
| Previous sepsis | 58.1% | 55.9% | 0.12 |
| Mortality | 57% | 42.9% | 0.07 |
Denotes statistical significance